Eisai Ltd ADR (ESALY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ESALY | UTHR | NBIX | ||
| Company | Eisai Ltd ADR | United Therapeutic | Neurocrine Bioscienc | ||
| Price Information | |||||
| Exchange | OTC US | NASDAQ | NASDAQ | ||
| Open | 62.5000 | 535.57 | 177.33 | ||
| High | 63.2900 | 536.15 | 177.33 | ||
| Low | 61.0000 | 523.46 | 169.04 | ||
| Latest | 61.5100 | 526.66 | 172.04 | ||
| Change | -1.3250 | -8.91 | -2.06 | ||
| % Change | -2.11% | -1.66% | -1.18% | ||
| Volume | 331,801 | 372,600 | 1,054,000 | ||
| 20-Day Average Volume | 58,360 | 553,360 | 1,234,430 | ||
| Previous Close | 62.8350 | 535.57 | 174.10 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 64.1255 | 546.07 | 168.46 | ||
| 20-Day Raw Stochastic | 13.14% | 7.95% | 64.68% | ||
| 20-Day Relative Strength | 42.88 | 40.59 | 58.85 | ||
| Weighted Alpha | +14.94 | +49.25 | +36.16 | ||
| Today's Opinion | 40% Buy | 8% Sell | 100% Buy | ||
| Previous Opinion | 40% Buy | 8% Buy | 100% Buy | ||
| Last Month's Opinion | 64% Buy | 40% Buy | 88% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -6.08% since 01/23/23 | -6.57% since 07/07/26 | -3.07% since 07/07/26 | ||
| Low | 61.0000 on 01/30/23 | 523.46 on 07/14/26 | 169.04 on 07/14/26 | ||
| High | 64.7200 on 01/26/23 | 563.24 on 07/08/26 | 181.18 on 07/10/26 | ||
| 1-Month | |||||
| %Chg | -7.24% since 12/30/22 | -3.54% since 06/12/26 | +7.69% since 06/12/26 | ||
| Low | 60.4000 on 01/05/23 | 523.46 on 07/14/26 | 155.30 on 06/16/26 | ||
| High | 68.8500 on 01/06/23 | 563.70 on 07/07/26 | 181.18 on 07/10/26 | ||
| 3-Month | |||||
| %Chg | +1.67% since 10/28/22 | -8.97% since 04/14/26 | +31.52% since 04/14/26 | ||
| Low | 56.8800 on 11/09/22 | 523.46 on 07/14/26 | 126.49 on 04/29/26 | ||
| High | 73.9035 on 12/05/22 | 609.35 on 05/06/26 | 181.18 on 07/10/26 | ||
| 6-Month | |||||
| %Chg | +34.10% since 07/29/22 | +10.71% since 01/14/26 | +27.13% since 01/14/26 | ||
| Low | 39.1540 on 09/07/22 | 455.63 on 01/20/26 | 122.14 on 02/12/26 | ||
| High | 73.9035 on 12/05/22 | 609.35 on 05/06/26 | 181.18 on 07/10/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 17,638,976 | 22,733,336 | 17,505,756 | ||
| Shares Outstanding, K | 286,766 | 42,447 | 100,550 | ||
| Annual Sales | 6,730,410,000 | 3,182,700,000 | 2,860,500,000 | ||
| Annual Net Income | 426,790,000 | 1,334,700,000 | 478,600,000 | ||
| Last Quarter Sales | 1,262,920,000 | 781,500,000 | 814,500,000 | ||
| Last Quarter Net Income | 25,840,000 | 274,900,000 | 197,900,000 | ||
| 60-Month Beta | 0.31 | 0.58 | 0.39 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 0.09 on 11/07/22 | 5.82 on 05/06/26 | 1.94 on 05/05/26 | ||
| Earnings Date | 02/02/23 | 07/29/26 | 07/30/26 | ||
| Most Recent Dividend | 0.440 on 09/27/22 | N/A | N/A | ||
| Next Ex-Dividends Date | 09/27/22 | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 72.22 | 20.19 | 29.82 | ||